Hims & Hers Health revenue and financials
In the fiscal year ended December 2025, Hims & Hers Health reported revenue of $2.35B (+59.00% year over year). Net income was $128.37M, a net margin of 5.5%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +59.00%
- 2025 vs 2024
- Net income growth
- +1.85%
- 2025 vs 2024
- Net margin
- 5.5%
- 2024: 8.5%
How Hims & Hers Health is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 73.6% a year on average over the last 5 years
Compound annual growth rate: from $148.76M in 2020 to $2.35B in 2025.
Revenue has grown for 7 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −12.6% to 5.2%
Operating income over revenue, 2022 → 2025: 17.8 percentage points.
Profits turn into cash: free cash flow equal to 147% of net income
Totals for fiscal years 2023–2025: free cash flow $339.65M, net income $230.86M.
Shares outstanding up 630.4% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 2 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,348 | 1,477 | 872 | 527 | 272 | 149 | 82.6 | 26.7 |
| Cost of revenue | 614 | 303 | 157 | 118 | 67.4 | 39.3 | 38.0 | 18.9 |
| Gross profit | 1,733 | 1,173 | 715 | 409 | 204 | 109 | 44.6 | 7.8 |
| Selling, general and administrative | 1,463 | 1,028 | 693 | 446 | 289 | 113 | 119 | 83.6 |
| Research and development | 149 | 78.8 | 48.2 | 29.2 | 22.4 | 11.2 | — | — |
| Operating income | 121 | 65.9 | -26.4 | -66.4 | -107 | -15.1 | -74.4 | -75.8 |
| EBIT | 121 | 65.9 | -26.4 | -66.4 | -107 | -15.1 | -74.4 | -75.8 |
| EBITDA | 176 | 83.0 | -16.9 | -58.9 | -103 | -14.1 | -74.2 | — |
| Interest expense | 3.9 | — | — | — | 0.0 | 0.0 | 0.4 | 0.2 |
| Pre-tax income | 124 | 71.7 | -21.6 | -65.7 | -111 | -18.0 | -72.0 | -75.2 |
| Income tax | -4.4 | -54.3 | 2.0 | -0.0 | -3.1 | 0.1 | 0.1 | 0.0 |
| Net income | 128 | 126 | -23.5 | -65.7 | -108 | -18.1 | -72.1 | -75.2 |
| Net income to common shareholders | 128 | 126 | -23.5 | -65.7 | -108 | -18.1 | -72.1 | -75.2 |
| Basic EPS | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 | -1.12 |
| Diluted EPS | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 | -1.12 |
| Average shares (basic) | 225 | 216 | 209 | 205 | 187 | 35.4 | 34.8 | 67.3 |
| Average shares (diluted) | 258 | 237 | 209 | 205 | 187 | 35.4 | 34.8 | 67.3 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 890 | 753 | 608 | 618 | 599 | 545 | 586 | 481 | 402 | 316 | 278 | 247 |
| Cost of revenue | 381 | 272 | 183 | 173 | 157 | 129 | 155 | 112 | 83.7 | 59.0 | 49.1 | 42.6 |
| Gross profit | 509 | 481 | 425 | 444 | 442 | 416 | 431 | 370 | 318 | 257 | 229 | 204 |
| Selling, general and administrative | 506 | 522 | 426 | 387 | 390 | 352 | 343 | 325 | 274 | 227 | 204 | 188 |
| Research and development | 69.4 | 54.9 | 46.9 | 41.0 | 40.6 | 37.8 | 29.9 | 23.7 | 21.1 | 18.6 | 15.2 | 13.4 |
| Operating income | -66.1 | -96.0 | -48.0 | 16.8 | 11.8 | 26.7 | 57.9 | 21.2 | 22.4 | 11.1 | 10.0 | 2.6 |
| EBIT | -66.1 | -96.0 | -48.0 | 16.8 | 11.8 | 26.7 | 57.9 | 21.2 | 22.4 | 11.1 | 10.0 | 2.6 |
| EBITDA | -27.9 | -66.6 | -26.1 | 34.9 | 29.5 | 37.2 | 66.2 | 27.2 | 26.8 | 14.7 | 13.0 | 5.3 |
| Interest expense | 5.5 | 3.7 | 2.9 | 0.9 | 1.9 | 1.1 | 0.1 | — | — | — | — | — |
| Pre-tax income | -46.3 | -92.6 | -102 | 18.4 | 12.2 | 32.9 | 60.5 | 22.3 | 23.6 | 13.4 | 12.4 | 2.2 |
| Income tax | -13.2 | -6.3 | -9.4 | -2.2 | -3.6 | -9.7 | 11.0 | -3.7 | -52.0 | 0.1 | 1.3 | 1.0 |
| Net income | -33.0 | -86.3 | -92.1 | 20.6 | 15.8 | 42.5 | 49.5 | 26.0 | 75.6 | 13.3 | 11.1 | 1.2 |
| Net income to common shareholders | -33.0 | -86.3 | -92.1 | 20.6 | 15.8 | 42.5 | 49.5 | 26.0 | 75.6 | 13.3 | 11.1 | 1.2 |
| Basic EPS | -0.14 | -0.37 | -0.40 | 0.09 | 0.07 | 0.19 | 0.22 | 0.12 | 0.35 | 0.06 | 0.05 | 0.01 |
| Diluted EPS | -0.14 | -0.37 | -0.40 | 0.09 | 0.06 | 0.17 | 0.20 | 0.11 | 0.32 | 0.06 | 0.05 | 0.01 |
| Average shares (basic) | 234 | 232 | 228 | 227 | 226 | 224 | 222 | 219 | 217 | 215 | 213 | 212 |
| Average shares (diluted) | 234 | 232 | 228 | 248 | 249 | 257 | 247 | 241 | 235 | 235 | 229 | 222 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 2,155 | 708 | 441 | 366 | 421 | 119 | 72.1 | 47.5 |
| Current assets | 768 | 396 | 265 | 217 | 270 | 113 | 69.6 | 47.3 |
| Cash and equivalents | 229 | 221 | 96.7 | 46.8 | 71.8 | 27.3 | 22.6 | 41.5 |
| Short-term investments | 349 | 79.7 | 124 | 133 | 175 | 72.9 | 37.7 | — |
| Receivables | 32.1 | 6.1 | 6.7 | 3.2 | 3.6 | 0.8 | 0.9 | 0.5 |
| Inventory | 80.1 | 64.4 | 22.5 | 21.6 | 13.6 | 3.5 | 4.2 | 3.7 |
| Net property, plant and equipment | 449 | 93.0 | 45.7 | 16.1 | 7.3 | 1.7 | 0.2 | — |
| Goodwill | 278 | 113 | 111 | 111 | 111 | — | — | — |
| Other intangible assets | 196 | 43.4 | 18.6 | 21.8 | 31.6 | 2.9 | 1.3 | — |
| Long-term investments | 351 | 0.0 | — | — | — | — | — | — |
| Current liabilities | 404 | 221 | 88.5 | 47.9 | 79.2 | 15.2 | 20.6 | 24.1 |
| Accounts payable | 143 | 91.2 | 43.1 | 32.4 | 19.6 | 8.1 | 7.2 | 13.3 |
| Long-term debt | 973 | — | — | — | — | — | — | 0.6 |
| Total debt | 1,121 | 11.3 | 9.9 | 5.3 | 5.5 | — | 1.5 | 8.4 |
| Total liabilities | 1,614 | 231 | 97.2 | 54.6 | 86.0 | 15.6 | 25.1 | 24.7 |
| Total equity (incl. minority) | 541 | 477 | 344 | 312 | 335 | 103 | 46.9 | 22.8 |
| Retained earnings | -114 | -242 | -368 | -345 | -279 | -171 | -153 | -81.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3,547 | 3,629 | 2,267 | 2,155 | 2,233 | 1,878 | 892 | 708 | 602 | 481 | 448 | 441 |
| Current assets | 1,321 | 1,385 | 1,045 | 768 | 845 | 1,356 | 447 | 396 | 326 | 291 | 262 | 265 |
| Cash and equivalents | 606 | 610 | 222 | 229 | 346 | 1,125 | 274 | 221 | 166 | 129 | 105 | 96.7 |
| Short-term investments | 107 | 231 | 529 | 349 | 284 | 20.0 | 48.9 | 79.7 | 88.6 | 98.0 | 98.4 | 124 |
| Receivables | 428 | 375 | 150 | 32.1 | 41.3 | 6.7 | 6.9 | 6.1 | 4.6 | 5.6 | 6.4 | 6.7 |
| Inventory | 108 | 87.8 | 79.1 | 80.1 | 106 | 142 | 76.1 | 64.4 | 49.1 | 40.6 | 29.8 | 22.5 |
| Net property, plant and equipment | 568 | 530 | 478 | 449 | 407 | 277 | 218 | 93.0 | 63.0 | 60.6 | 56.6 | 45.7 |
| Goodwill | 1,111 | 1,102 | 343 | 278 | 259 | 118 | 118 | 113 | 113 | 111 | 111 | 111 |
| Other intangible assets | 397 | 423 | 261 | 196 | 195 | 40.7 | 43.4 | 43.4 | 44.8 | 17.1 | 17.9 | 18.6 |
| Long-term investments | 0.0 | 31.2 | 31.2 | 351 | 438 | — | — | — | — | — | — | — |
| Current liabilities | 1,436 | 1,483 | 619 | 404 | 451 | 272 | 280 | 221 | 153 | 109 | 93.3 | 88.5 |
| Accounts payable | 516 | 501 | 307 | 143 | 198 | 105 | 109 | 91.2 | 75.4 | 57.1 | 43.9 | 43.1 |
| Long-term debt | 1,367 | 1,365 | 974 | 973 | 971 | 969 | — | — | — | — | — | — |
| Total debt | 1,561 | 1,546 | 1,132 | 1,121 | 1,118 | 1,044 | 63.4 | 11.3 | 11.4 | 11.5 | 11.8 | — |
| Total liabilities | 3,192 | 3,305 | 1,821 | 1,614 | 1,652 | 1,315 | 342 | 231 | 162 | 119 | 104 | 97.2 |
| Total equity (incl. minority) | 355 | 324 | 446 | 541 | 581 | 563 | 549 | 477 | 440 | 362 | 344 | 344 |
| Retained earnings | -325 | -292 | -206 | -114 | -134 | -150 | -193 | -242 | -268 | -344 | -357 | -368 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 300 | 251 | 73.5 | -26.5 | -34.4 | -2.5 | -74.9 | -57.3 |
| Depreciation and amortization | 54.5 | 17.1 | 9.5 | 7.5 | 4.1 | 1.1 | 0.3 | — |
| Capital expenditure | -226 | -41.7 | -17.2 | -2.7 | -0.8 | -1.7 | -0.3 | -0.0 |
| Investing cash flow | -1,025 | -19.0 | -12.1 | 34.7 | -156 | -39.7 | -39.3 | -0.0 |
| Financing cash flow | 730 | -108 | -11.5 | -33.1 | 235 | 47.7 | 95.3 | 78.2 |
| Share repurchases | -207 | -136 | -16.1 | -3.9 | -28.0 | 0.0 | 0.0 | — |
| Debt issued | 970 | 0.0 | 0.0 | 0.0 | — | — | 2.1 | 9.4 |
| Debt repaid | — | — | — | 0.0 | 0.0 | -1.5 | -9.1 | -1.9 |
| Effect of exchange rates | 2.5 | -0.3 | -0.0 | -0.1 | -0.1 | -0.0 | -0.0 | -0.0 |
| Net change in cash | 7.2 | 124 | 49.9 | -25.0 | 44.3 | 5.6 | -18.9 | 20.8 |
| Free cash flow | 74.0 | 209 | 56.3 | -29.2 | -35.2 | — | — | — |
| Levered free cash flow | 111 | 179 | 66.4 | -44.4 | 52.5 | -14.0 | -40.8 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 65.4 | -35.9 | 89.4 | 61.3 | 149 | -19.1 | 109 | 86.4 | 85.3 | 53.6 | 25.8 | 22.0 |
| Depreciation and amortization | 38.2 | 29.5 | 22.0 | 18.1 | 17.7 | 10.5 | 8.3 | 6.1 | 4.4 | 3.6 | 3.0 | 2.7 |
| Capital expenditure | -33.3 | -25.9 | -29.8 | -59.4 | -65.3 | -46.1 | -55.3 | -24.5 | -3.3 | -3.2 | -10.6 | -8.6 |
| Investing cash flow | -55.4 | 84.5 | -15.4 | -83.7 | -887 | -21.1 | -32.8 | -17.2 | -10.4 | -4.5 | 13.0 | 20.7 |
| Financing cash flow | -18.9 | 342 | -77.9 | -97.5 | -39.0 | 889 | -23.0 | -13.7 | -38.8 | -25.1 | -30.3 | -4.0 |
| Share repurchases | -18.9 | -23.1 | -39.2 | -102 | -42.0 | -36.8 | -25.7 | -24.4 | -40.9 | -34.9 | -35.4 | -6.0 |
| Debt issued | 0.0 | 390 | — | 0.0 | 0.0 | 970 | — | — | — | — | — | — |
| Effect of exchange rates | 4.7 | -2.8 | -2.4 | 2.7 | -1.5 | 1.0 | 0.2 | -0.5 | 0.2 | -0.0 | 0.0 | -0.0 |
| Net change in cash | -4.2 | 388 | -6.4 | -117 | -779 | 850 | 53.5 | 55.1 | 36.2 | 24.1 | 8.6 | 38.7 |
| Free cash flow | 32.1 | -61.9 | 59.5 | 1.9 | 83.5 | -65.2 | 53.8 | 61.9 | 81.9 | 50.4 | 15.3 | 13.4 |
| Levered free cash flow | -101 | 588 | 102 | -22.0 | 170 | -81.2 | 38.7 | 62.1 | 72.5 | 38.4 | 4.8 | 11.1 |
Financial statements of similar companies
Companies in the group: same industry, similar size
